Premier Health Appoints New CEO for 2027
The incoming leader brings 27 years of experience to the Dayton health system as it shifts executive strategy.
Updated on Oct. 22, 2026 in People
Live Poll
Do you trust that changes in health system leadership will improve patient care in your area?
Premier Health has appointed Rosanna Morris as its next president and CEO following a unanimous board decision. Morris will succeed outgoing leader Michael Riordan in the first quarter of 2027.
Why it matters
The leadership change at Dayton's largest health system signals a shift in operational strategy as the organization transitions away from Michael Riordan's five-year tenure. Operators should monitor how Morris, who has 27 years of experience, integrates her background in academic medicine into local operations.
Rosanna Morris brings 27 years of executive healthcare experience to Premier Health, succeeding Michael Riordan who served a five-year term. The health system operates with a multi-billion dollar budget.
The players
Rosanna Morris
Incoming president and CEO of Premier Health with 27 years of healthcare executive experience.
Premier Health
A major Dayton-based health system that serves as a regional healthcare provider.
Michael Riordan
Outgoing president and CEO who concluded a five-year leadership tenure.
University of Texas MD Anderson Cancer Center
A prominent academic medical institution where Morris serves as executive vice president.
The details
The Premier Health Board of Trustees selected Morris following a national search to replace the outgoing CEO. Morris, a registered nurse by training, currently serves as the executive vice president and chief clinical operating officer at the University of Texas MD Anderson Cancer Center. She previously held executive roles at Nebraska Medicine and served as president of Beaumont Hospital-Royal Oak.
Timeline
October 22, 2026: Appointment of Rosanna Morris announced.
Q1 2027: Rosanna Morris begins her term as president and CEO.
Market Landscape
The leadership transition follows the retirement of Michael Riordan after five years, marking a shift in executive strategy for the regional health system. This move concludes a national search process to replace the long-term incumbent.
Local vendors and partners should prepare for potential adjustments in health system procurement and service priorities when Morris assumes control in early 2027. Maintain contact with current department leads through the transition period to gauge how incoming leadership will align with existing contracts.
The takeaway
The appointment of a new CEO with an academic medicine background suggests a possible pivot toward research-heavy clinical models at the regional health level. Operators should track updates from the senior leadership team in the coming months for signals on capital expenditure shifts.
Further reading
For more on shifting leadership roles in the local economy, visit People.
Live Poll
Do you trust that changes in health system leadership will improve patient care in your area?
